These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10844707)

  • 1. Measuring cognitive change in a cohort of patients with Alzheimer's disease.
    Galasko DR; Gould RL; Abramson IS; Salmon DP
    Stat Med; 2000 Jun 15-30; 19(11-12):1421-32. PubMed ID: 10844707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of cognitive change in Alzheimer's disease: methodological approaches using random effects models.
    Gould R; Abramson I; Galasko D; Salmon D
    J Int Neuropsychol Soc; 2001 Nov; 7(7):813-24. PubMed ID: 11771624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
    Tiraboschi P; Hansen LA; Alford M; Merdes A; Masliah E; Thal LJ; Corey-Bloom J
    Arch Gen Psychiatry; 2002 Oct; 59(10):946-51. PubMed ID: 12365882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
    Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
    Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    Giil LM; Aarsland D
    J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.
    Kramberger MG; Auestad B; Garcia-Ptacek S; Abdelnour C; Olmo JG; Walker Z; Lemstra AW; Londos E; Blanc F; Bonanni L; McKeith I; Winblad B; de Jong FJ; Nobili F; Stefanova E; Petrova M; Falup-Pecurariu C; Rektorova I; Bostantjopoulou S; Biundo R; Weintraub D; Aarsland D;
    J Alzheimers Dis; 2017; 57(3):787-795. PubMed ID: 28304294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
    Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
    Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cognitive impairment in subjects with geriatric depression who will develop Alzheimer's disease and other dementias: a retrospective study.
    Jean L; Simard M; van Reekum R; Clarke DE
    Int Psychogeriatr; 2005 Jun; 17(2):289-301. PubMed ID: 16050437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile.
    Peavy GM; Salmon DP; Rice VA; Galasko D; Samuel W; Taylor KI; Ernesto C; Butters N; Thal L
    Arch Neurol; 1996 Apr; 53(4):367-72. PubMed ID: 8929160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.
    Rasquin SM; Lodder J; Visser PJ; Lousberg R; Verhey FR
    Dement Geriatr Cogn Disord; 2005; 19(2-3):113-9. PubMed ID: 15591801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse.
    Blanc F; Mahmoudi R; Jonveaux T; Galmiche J; Chopard G; Cretin B; Demuynck C; Martin-Hunyadi C; Philippi N; Sellal F; Michel JM; Tio G; Stackfleth M; Vandel P; Magnin E; Novella JL; Kaltenbach G; Benetos A; Sauleau EA
    Alzheimers Res Ther; 2017 Jun; 9(1):47. PubMed ID: 28655337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in the mini-mental state exam in Alzheimer's disease over 2 years: the experience of a dementia clinic.
    McCarten JR; Rottunda SJ; Kuskowski MA
    J Alzheimers Dis; 2004 Feb; 6(1):11-5. PubMed ID: 15004323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
    Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis testing of a change point during cognitive decline among Alzheimer's disease patients.
    Ji M; Xiong C; Grundman M
    J Alzheimers Dis; 2003 Oct; 5(5):375-82. PubMed ID: 14646028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study.
    Rongve A; Soennesyn H; Skogseth R; Oesterhus R; Hortobágyi T; Ballard C; Auestad BH; Aarsland D
    BMJ Open; 2016 Feb; 6(2):e010357. PubMed ID: 26928028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Ala TA; Hughes LF; Kyrouac GA; Ghobrial MW; Elble RJ
    Int J Geriatr Psychiatry; 2002 Jun; 17(6):503-9. PubMed ID: 12112173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
    J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial.
    Querfurth HW; Allam GJ; Geffroy MA; Schiff HB; Kaplan RF
    Dement Geriatr Cogn Disord; 2000; 11(6):314-21. PubMed ID: 11044776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.